Terms: = Pancreatic cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Treatment
13 results:
1. Nomogram incorporating prognostic immune-inflammatory-nutritional score for survival prediction in pancreatic cancer: a retrospective study.
Yang J; Zhou H; Li H; Zhao F; Tong K
BMC Cancer; 2024 Feb; 24(1):193. PubMed ID: 38347528
[TBL] [Abstract] [Full Text] [Related]
2. A Gallbladder cancer Survival Prediction Model Based on Multimodal Fusion Analysis.
Yin Z; Chen T; Shu Y; Li Q; Yuan Z; Zhang Y; Xu X; Liu Y
Dig Dis Sci; 2023 May; 68(5):1762-1776. PubMed ID: 36496528
[TBL] [Abstract] [Full Text] [Related]
3. Oral anticoagulants but not antiplatelet agents increase the risk of delayed bleeding after endoscopic papillectomy: a large study in a tertiary referral center.
Meunier C; Lisotti A; Gupta V; Lemaistre AI; Fumex F; Gincul R; Lefort C; Lepillez V; Bourdariat R; Napoléon B
Surg Endosc; 2022 Oct; 36(10):7376-7384. PubMed ID: 35233659
[TBL] [Abstract] [Full Text] [Related]
4. [Effect and mechanism of siRNA targeting α-enolase gene combined with paclitaxel on proliferation, invasion and apoptosis of hepatocellular carcinoma cell].
Cui H; Gao QQ; Zhuang H; He T; Wan BS; Wang XQ; Zhang L; Huang T; Han F
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1241-1247. PubMed ID: 34915631
[No Abstract] [Full Text] [Related]
5. Predictors of conversion surgery in patients with pancreatic cancer who underwent neoadjuvant or palliative FOLFIRINOX treatment using baseline and follow-up CT.
Park SJ; Kim JH; Joo I; Han JK
Abdom Radiol (NY); 2021 Oct; 46(10):4765-4778. PubMed ID: 34085090
[TBL] [Abstract] [Full Text] [Related]
6. Metformin and Gastrointestinal cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea.
You JH; Song SO; Kang MJ; Cho YY; Kim SW; Suh SH; Lee S; Lee YH; Lee BW
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00254. PubMed ID: 33105165
[TBL] [Abstract] [Full Text] [Related]
7. A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.
Ryu T; Takami Y; Wada Y; Tateishi M; Hara T; Yoshitomi M; Momosaki S; Yasumori K; Saitsu H; Okuda K
J Gastrointest Surg; 2019 Apr; 23(4):779-787. PubMed ID: 30788712
[TBL] [Abstract] [Full Text] [Related]
8. Integrated Molecular Characterization of the Lethal Pediatric cancer Pancreatoblastoma.
Isobe T; Seki M; Yoshida K; Sekiguchi M; Shiozawa Y; Shiraishi Y; Kimura S; Yoshida M; Inoue Y; Yokoyama A; Kakiuchi N; Suzuki H; Kataoka K; Sato Y; Kawai T; Chiba K; Tanaka H; Shimamura T; Kato M; Iguchi A; Hama A; Taguchi T; Akiyama M; Fujimura J; Inoue A; Ito T; Deguchi T; Kiyotani C; Iehara T; Hosoi H; Oka A; Sanada M; Tanaka Y; Hata K; Miyano S; Ogawa S; Takita J
Cancer Res; 2018 Feb; 78(4):865-876. PubMed ID: 29233928
[TBL] [Abstract] [Full Text] [Related]
9. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.
Martin RC; Durham AN; Besselink MG; Iannitti D; Weiss MJ; Wolfgang CL; Huang KW
J Surg Oncol; 2016 Dec; 114(7):865-871. PubMed ID: 27546233
[TBL] [Abstract] [Full Text] [Related]
10. Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) performed in patients with Periampullary duodenal diverticula (PAD).
Zippi M; Traversa G; Pica R; De Felici I; Cassieri C; Marzano C; Occhigrossi G; Paoluzi P
Clin Ter; 2014; 165(4):e291-4. PubMed ID: 25203345
[TBL] [Abstract] [Full Text] [Related]
11. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas.
Tomimaru Y; Takeda Y; Tatsumi M; Kim T; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Nagano H; Umeshita K; Wakasa K; Doki Y; Mori M
Oncol Rep; 2010 Sep; 24(3):613-20. PubMed ID: 20664965
[TBL] [Abstract] [Full Text] [Related]
12. Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.
Teschendorf C; Emons B; Muzyczka N; Graeven U; Schmiegel W
Anticancer Res; 2010 Jun; 30(6):1931-5. PubMed ID: 20651336
[TBL] [Abstract] [Full Text] [Related]
13. treatment cost of pancreatic cancer in Japan: analysis of the difference after the introduction of gemcitabine.
Ishii H; Furuse J; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotohda N; Nakachi K; Suzuki E; Yoshino M
Jpn J Clin Oncol; 2005 Sep; 35(9):526-30. PubMed ID: 16120621
[TBL] [Abstract] [Full Text] [Related]
